Efferon

Efferon is an Austrian biotech company that designs multimodal hemoadsorption cartridges used to strip endotoxins and inflammatory cytokines from the bloodstream, primarily as an ICU therapy for sepsis and septic shock. Its product line spans Efferon LPS for adult patients and Efferon NEO for pediatric and neonatal use, with the technology approved and deployed across more than 40 countries. Manufacturing sits in Estonia and Latvia, with commercial offices in Austria and the United States.

  • Seed
  • Biotechnology
  • Healthtech
  • Medical Devices
  • Healthcare & Life Sciences

1

Round

1

Industry

4

Tags

Nov 10, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 10, 2026

    EUR 4.8M

    Seed

    Article coming soon.

Pricing

Research Efferon — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Efferon is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational